What is the Market's View on Biomerica Inc (BMRA) Stock's Price and Volume Trends Friday?

The market has been down on Biomerica Inc (BMRA) stock recently. BMRA gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Biomerica Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BMRA!

See Full BMRA Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BMRA Stock Today?

Biomerica Inc (BMRA) stock is higher by 2.43% while the S&P 500 has fallen -0.62% as of 1:26 PM on Friday, Dec 2. BMRA is higher by $0.09 from the previous closing price of $3.70 on volume of 28,120 shares. Over the past year the S&P 500 is lower by -10.23% while BMRA has fallen -14.45%. BMRA lost -$0.39 per share in the over the last 12 months.

More About Biomerica Inc

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market. Click Here to get the full Stock Report for Biomerica Inc stock.